API Unit-IV, Nacharam (CDMO Wing)

Our API Unit-IV, Nacharam (CDMO Wing) is a hi-potent API and intermediate manufacturing facility that combines advanced infrastructure, diverse reactor capabilities, and global regulatory accreditations to deliver reliable, scalable, and compliant solutions. With 63 reactors totaling 36.84 KL, specialized equipment, and robust utilities, the site is designed for flexibility, precision, and safety in handling complex, high-potency molecules. Accredited by the USFDA, EDQM, ISO, and WHO, the facility enables pharmaceutical partners worldwide to accelerate development, scale seamlessly, and bring high-quality therapies to market with confidence.